In this insightful discussion, Doug Bain, founder of ClinFlow, Drew Garty, CTO at Veeva, and Robert Bergann, leader of clinical digital innovation at Bayer, delve into the transformative power of AI in clinical development. They share practical AI use cases like pattern detection and the innovation of automated study builds. The guests also discuss the importance of human oversight in AI outputs, effective governance for AI strategies, and the need for proactive detection methods. Their call to action emphasizes focusing AI on patient benefits and quality data.
